New regulation in Russia disrupts supply of veterinary drugs
Recently, it became known that Russian livestock breeders have enough stocks of imported veterinary drugs for only two to three months.
The reason for this shortage is the introduction of new GMP registration requirements for foreign pharmaceutical manufacturers, which came into force on September 1, 2023. These requirements led to the loss of 600 key high-tech veterinary drugs by Russia. Industry experts estimate stocks of imported drugs from livestock farmers until the end of the year at the most.
Despite the fact that veterinary drugs account for only 1-3% of the cost of livestock products, their absence or misuse can lead to serious consequences, up to the loss of the entire herd.
Therefore, it is important to have access to reliable and effective veterinary medicines.
The replacement of high-tech imported drugs requires considerable time. For example, India and China, which are considered countries with developed livestock production, still import 30-35% of pharmaceuticals for their industry. This suggests that the complete replacement of imported drugs will take a lot of time and efforts.
According to experts, Russia is provided with domestic pharmaceuticals to combat particularly dangerous animal diseases. Also, chemical and pharmaceutical preparations are actively imported and produced by domestic players of the pharmaceutical market. However, the situation with vaccines against economically significant diseases in Russia leaves much to be desired, since up to 90-95% of vaccines are still imported.
At the moment, the share distribution of the main categories of veterinary drugs is as follows: 35% – import of commercial vaccines, 28% – import of chemical and pharmaceutical products, 25% – domestic production. This indicates the need to develop the domestic pharmaceutical industry and increase the share of domestic veterinary drugs in the market.
SOURCE: piginfo